Analysis of the involvement of human N-acetyltransferase 1 in the genotoxic activation of bladder carcinogenic arylamines using a SOS/umu assay system

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 554, Issue 1-2, 2004, Pages 399-406

  Oda, Yoshimitsu ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

Arylamines; Genotoxicity; Human acetyltransferases; umu test

Indexed keywords

2 METHYLANILINE; 2 NAPHTHYLAMINE; 4 BIPHENYLAMINE; 5 IODOSALICYLIC ACID; ACYLTRANSFERASE; ACYLTRANSFERASE INHIBITOR; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; BENZIDINE; CYTOCHROME P450 1A2; N (2 FLUORENYL)ACETAMIDE; N ACETYLTRANSFERASE 1; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BLADDER CARCINOGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; ENZYME ACTIVITY; ENZYME ANALYSIS; FUSION GENE; GENE ACTIVATION; GENE EXPRESSION; GENE INDUCTION; GENOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SALMONELLA TYPHIMURIUM; TOXICITY TESTING;

AMINES; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOGENS; CYTOCHROME P-450 CYP1A2; HUMANS; ISOENZYMES; NADPH-FERRIHEMOPROTEIN REDUCTASE; RECOMBINANT PROTEINS; SOS RESPONSE (GENETICS); URINARY BLADDER NEOPLASMS;

RODENTIA; SALMONELLA TYPHIMURIUM;

EID: 4344582935     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrfmmm.2004.06.033     Document Type: Article

References (47)

1. P.A. Schlte, E. Ward, M. Boeniger, and B. Hills Occupational exposure to N-substituted aryl compounds C.M. King L.J. Romano D. Schuetzle Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes 1988 Elsevier New York pp. 23-36
2. M.R. Guerin, and M.V. Buchanan Environmental exposure to N-substituted aryl compounds C.M. King L.J. Romano D. Schuetzle Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes 1988 Elsevier New York pp. 23-36
3. F.F. Kadlubar Biochemical individuality implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans Drug Metabol. Rev. 26 1994 37 46
4. F.P. Guengerich, and T. Shimada Activation of procarcinogens by human cytochrome P450 enzymes Mutat. Res. 400 1998 201 213
5. J.A. Boyd, E. Zeiger, and T.E. Eling The prostaglandin H synthase-dependent activation of 2-aminofluorene to products mutagenic to S.typhimurium strains TA98 and TA98NR Mutat. Res. 143 1985 187 190
6. L.D. Morrison, T.E. Eling, and P.D. Josephy Prostaglandin H synthase-dependent formation of the direct-acting mutagen 2-nitro-3- methylimidazo[4,5-f]quinoline (nitro-IQ) from IQ Mutat. Res. 302 1993 45 52
7. J. Chen, M.J. Stampfer, H.L. Hough, M. Garcia-Closas, W.C. Willett, C.H. Hennekens, K.T. Kelsey, and D.J. Hunter A prospective study of N-acetyltransferase genotype red meat intake, and risk of colorectal cancer Cancer Res. 58 1998 3307 3311
8. R.A. Cartwright, R.W. Glashan, H.J. Rogers, R.A. Ahmad, D. Barham-Hall, E. Higgins, and M.A. Kahn Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer Lancet 2 1982 842 845
9. P. Vineis, H. Bartsch, N. Caporaso, A.M. Harrington, F.F. Kadlubar, and S.R. Tannenbaum Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens Nature (London) 369 1994 154 156
10. D.W. Hein Acetylator genotype and arylamine-induced carcinogenesis Biochem. Biophys. Acta 948 1988 37 66
11. D.W. Grant, P.D. Josephy, H.L. Lord, and L.D. Morrison Salmonella typhimurium strains expressing human arylamine N-acetyltransferase: metabolism and mutagenic activation of aromatic amines Cancer Res. 52 1992 3961 3964
12. D.W. Hein Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis Mutat. Res. 506-507 2002 65 77
13. Y. Oda, H. Yamazaki, and T. Shimada Role of human N-acetyltransferases, NAT1 or NAT2, in genotoxicity of nitroarenes and aromatic amines in Salmonella typhimurium NM6001 and NM6002 Carcinogenesis 20 1999 1079 1083
14. Y. Oda, H. Yamazaki, M. Watanabe, T. Nohmi, and T. Shimada Highly sensitive umu test system for the detection of mutagenic nitroarenes in Salmonella typhimurium NM3009 having high O-acetyltransferase and nitroreductase activities Environ. Mol. Mutagen. 21 1993 357 364
15. Y. Oda, H. Yamazaki, and T. Shimada Development of high sensitivity umu test system: rapid detection of genotoxicity of promutagenic aromatic amines by Salmonella typhimurium NM2009 possessing high O-acetyltransferase activity Mutat. Res. 334 1995 145 156
16. T. Shimada, Y. Oda, H. Yamazaki, M. Mimura, and F.P. Guengerich SOS function tests for studies of chemical carcinogenesis in Salmonella typhimurium TA1535/pSK1002 NM2009 and NM3009 K.W. Adolph Methods in Molecular Genetics, Vol. 5, Gene and Chromosome Analysis 1994 Academic Press Orlando, FL pp. 342-355
17. J.H. Miller, Experiments in Molecular Genetics, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, NY, 1972, pp. 352-355.
18. Y. Oda, S. Nakamura, I. Oki, T. Kato, and H. Shinagawa Evaluation of the new test system (umu-test) for the detection of environmental mutagens and carcinogens Mutat. Res. 147 1985 219 229
19. A. Purikh, M.J. Gillam, and F.P. Guengerich Drug metabolism by Escherichia coli expressing human cytochrome P450 Nat. Biotechnol. 15 1997 784 788
20. P. Aryal, K. Yoshikawa, T. Terashita, F.P. Guengerich, T. Shimada, and Y. Oda Development of a new genotoxicity test system with Salmonella typhimurium OY1001/1A2 expressing human CYP 1A2 and NADPH-P450 reductase Mutat. Res. 442 1999 113 120
21. R.A. Voice, M. Manis, and W.W. Weber Inhibition of human red blood cell N-acetyltransferase Drug Metab. Dispos. 21 1993 181 183
22. A. Upton, V. Smelt, A. Mushtaq, R. Aplin, N. Johnson, H. Mardon, and E. Sim Placental arylamine N-acetyltransferase type 1: potential contributory source of urinary folate catabolite p-acetamidobenzoylglutamate during pregnancy Biochim. Biophys. Acta 154 2000 143 148
23. M. Watanabe, A. Matsuoka, N. Yamazaki, M. Hayashi, T. Deguchi, T. Nohmi, and T. Sofuni New sublines of Chinese hamster CHL stably expressing human NAT1 or NAT2 N-acetyltransferases or Salmonella typhimurium O-acetyltransferase: comparison of the sensitivities to nitroarenes and aromatic amines using the in vitro micronucleus test Cancer Res. 54 1994 1672 1677
24. D. Wild, W. Feser, S. Michel, H.L. Lord, and P.D. Josephy Metabolic activation of heterocyclic amines catalyzed by human arylamine N-acetyltransferase isozymes (NAT1 and NAT2) express in Salmonella typhimurium Carcinogenesis 16 1995 643 648
25. R.F. Minchin, P.T. Reeves, C.H. Teitel, M.E. McManus, B. Mojarrabi, K.F. Ilett, and F.F. Kadlubar N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells Biochem. Biophys. Res. Commun. 185 1992 839 844
26. D.W. Hein, M.A. Doll, T.D. Rustan, K. Gray, R.J. Ferguson, and D.M. Grant Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases Carcinogenesis 14 1993 1633 1638
27. T.V. Zenser, V.M. Lakshmi, T.D. Rustan, M.A. Doll, A.C. Deitz, B.B. Davis, and D.W. Hein Human N-acetylation of benzidine: role of NAT1 and NAT2 Cancer Res. 56 1996 3941 3947
28. A.F. Badawi, A. Hirvonen, D.A. Bell, N.P. Lang, and F.F. Kadlubar Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder Cancer Res. 55 1995 5230 5237
29. S.M. Frederickson, J.F. Hatcher, C.A. Reznikoff, and S. Swaminathan Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells Carcinogenesis 13 1992 955 961
30. C. Guhe, G.H. Degan, U.S. Schuhmacher, F. Kiefer, and W. Follmann Drug metabolizing enzyme activities in porcine urinary bladder epithelial cell cultures (PUBEC) Arch. Toxicol. 70 1996 599 606
31. Anonymous, Bioassay of o-anisidine hydrochloride for possible carcinogenicity, NTP Technical Report, No. 89, 1978.
32. V.C. Dunkel, E. Zeiger, D. Brusick, E. McCoy, D. MacGregor, K. Mortelmans, H.S. Rosenkranz, and V.F. Simmon Reproducibility of microbial Mutagenicity assays: II. Testing of carcinogens and noncarcinogens in Salmonella and Escherichia coli Environ. Mutagen. 7 Suppl. 5 1985 1 248
33. E. Zeiger, A.B. Anderson, S. Haworth, T. Lawlor, and K. Mortelmans Salmonella mutagenicity tests, IV. Results from the testing of 300 chemicals Environ. Mutagn. 11 Suppl. 12 1988 1 57
34. D.C. Thompson, P.D. Josephy, J.W.K. Chu, and T.E. Eling Enhanced mutagenicity of anisidine isomer in bacterial strains containing elevated N-acetyltransferase activity Mutat. Res. 279 1992 83 89
35. C.Z. Tompson, L.E. Hill, J.K. Epp, and G.S. Probst The induction of bacterial mutation and hepatocyte unscheduled DNA synthesis by monosubstituted anilines Environ. Mutagen. 5 1983 803 811
36. S.M. Galloway, M.J. Armstrong, C. Reuben, S. Colman, B. Brown, C. Cannon, A.D. Bloom, F. Nakamura, M. Ahmed, S. Dunk, J. Rimpo, and B.M. Margolin Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells evaluations of 108 chemicals Environ. Mutagen. 10 Suppl. 10 1987 1 175
37. N. Yoshimi, S. Sugie, H. Iwata, K. Niwi, C. Mori, C. Hashida, and H. Shimizu The genotoxicity of a variety of aniline derivatives in a DNA repair test with primary cultured rat hepatocytes Mutat. Res. 206 1988 183 191
38. G.M. Williams, H. Mori, and C.A. McQueen Structure-activity relationships in the rat hepatocyte DNA repair test for 300 chemicals Mutat. Res. 221 1989 263 286
39. J. Ashby, P.A. Lefevre, H. Tinwell, G. Brunborg, P. Schmezer, B. Pool-Zobel, R. Shanu-Wilson, J.A. Holme, E.J. Soderlund, D. Gulati, and J.P. Wojciechowski The non-genotoxicity to rodent of the potent rodent bladder carcinogens o-anisidine and p-cresidine Mutat. Res. 250 1991 115 133
40. - assay of 300 compounds Environ. Mutagen. 8 Suppl. 6 1986 1 90
41. 32P bladder DNA adduction Carcinogenesis 15 1994 2291 2296
42. 32P-postlabelling analysis by DNA adduct formation Gen. Physiol. Biophys. 20 2001 267 279
43. D.A. Bell, A.F. Badawi, N.P. Lang, K.F. Ilett, F.F. Kadlubar, and A. Hirvonen Polymorphism in the N-acetyltransferase 1 polyadenylation signal: association of NAT1*10 allele with higher N-acetylation activity in bladder and colon tissue Cancer Res. 55 1995 5226 5229
44. J.A. Taylor, D.M. Umbach, E. Stephens, T. Castranio, D. Paulson, C. Roberson, J.L. Mohler, and D.A. Bec The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene exposure three-way interaction Cancer Res. 58 1998 3603 3610
45. I. Cascorbi, I. Roots, and J. Brockmoller Association of NAT1 and NAT2 polymorphism to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10 Cancer Res. 61 2001 5051 5056
46. H. Okkels, T. Sigsgaard, H. Wolf, and H. Autrup Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking Cancer Epidemiol. Biomarkers Prev. 6 1997 225 231
47. S.A.J. Vaziri, N.C. Hughes, H. Sampson, G. Darlington, M.A.S. Jewett, and D.M. Grant Variation in enzymes of arylamine procarcinogen biotransformation among bladder cancer patients and control subjects Pharmacogenetics 11 2001 7 20